BMGP MAJOR EBOLA DD Strong Buy super thin small SS and great DD (EBOLA)
http://www.biomagneticsbmgp.com/IOBS.html http://www.fda.gov/medicaldevices/safety/emergencysituations/ucm161... second paragraph on aug 5th FDA looking for a quicker scan for ebola Then look at IOBS on the product list for BMGP Then we have this http://www.biomagneticsbmgp.com/hts.html detects viral infections 3-4 times quicker than any other method http://trove.nla.gov.au/work/83035468?q=+&versionId=96347871 has two patents other diseases with similar symptoms such as malaria, cholera Thoose are the two closest disease to ebola We have products for both of them to detect and prevent earlier than anything else IOBS is good for the airport security as it takes no training to use Roadrunner 3 12:16 PM hese devices are specifically designed to be battery operated and ultraportable, allowing for the rapid detection of various viral and bacterial pathogens by relatively untrained personnel outside of the laboratory setting. These http://www.slideshare.net/Biomagnetics/bmgp-overview Page three of this says they were in serious negotions with major us health officials
High Throughput Screening - Magnetic Testing Platform (HTS-MTP)
HTS - MTP
Biomagnetics Diagnostics Corp. has designed a revolutionary system of diagnostics. Our High Throughput Screening – Magnetic Testing Platform (HTS-MTP) is designed to detect both qualitative (chemical identification of the elements present in a substance) and quantitative (number of specific elements in a substance) results from a single test.
Today's immunoassays (a chemical procedure for detecting infections) detect specific antibodies (blood proteins produced in response to and counteracting alien substances found in the body such as viruses and bacteria) but do not evaluate viral load (quantitative analysis), nor do they detect the antigen (the virus or bacteria itself). The HTS-MTP system utilizes technology that is simple in concept, but revolutionary in scope--allowing for the detection of the virus by "measuring" the magnetic field of micro-particles bonded to the virus in a fraction of the time and costs of existing assays. Most testing conducted in the United States today are screening assays (limited to the detection of antibodies), and are largely for detection purposes only. These tests are limited because they can only detect the presence of antibodies after a minimum infection time of two to six weeks. The Western Blot Test, the most widely used confirmatory test, again tests only for antibodies. The HTS-MTP system is designed to detect the virus (not the antibodies the human body produces to react to the virus) in a fraction of the time--72 to 96 hours. All with near 100% accuracy.
That document is a 2009 Emerging Growth Joe Noel production. BMGP is not producing anything. It's dark and hasn't produced audited financials in years. No news in years. Joe Noel, according to the last audited report from BMGP was paid millions of shares to promote BMGP. Emerging growth, the DD you cite is defunct and has been for years. Nothing that I read on that report has happened and BMGP is about 10 million in debt.
News 
Market Data 
Discover 
